Клинические и этиопатогенетические аспекты коморбидности депрессивных и тревожных нарушений: к проблеме достижения устойчивой ремиссии

Коморбидность депрессивных и тревожных нарушений — наиболее частая комбинация психиатрических расстройств, которая связана с более высоким риском суицидального поведения, медико-социальными и профессиональными проблемами. Клиническая картина коморбидных расстройств характеризуется трудностью верификации и осложняется возможностью формирования вторичных нарушений, таких как злоупотребление алкоголем и ПАВ. Этиопатогенетические механизмы включают сложное взаимодействие между биологическими и психологическими процессами. В связи с чем подчеркивается необходимость дальнейшей разработки алгоритмов диагностики, изучения комплексной терапии для достижения устойчивой ремиссии у пациентов с коморбидными депрессивными и тревожными нарушениями.

1. Васильева А.В., Караваева Т.А., Колесова Ю.П., Радионов Д.С., Старунская Д.А., Фомичева М.А., Абдуллаева С.М. Оценка эффективности комплексной медико-психологической методики лечения пациентов с инсомнией. Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева. 2023;57(4):30-41.

2. Климанова С.Г., Березина А.А., Трусова А.В., Подоляк Д.В., Рыбакова К.В., Крупицкий Е.М. Взаимосвязь клинических характеристик пациентов с алкогольной зависимостью с доминирующей мотивацией употребления алкоголя. Обозрение психиатрии и медицинской психологии им. В.М. Бехтерева. 2022;56(4):63-76.

3. Ковалев А.И. Клинические особенности сочетания агорафобии и психических расстройств непсихотического уровня. Медицинский вестник Юга России. 2022;13(2):146-153.

4. Мартынихин И.А. Использование МКБ-10 для диагностики психических расстройств в Рос- сии: по данным государственной статистики и результатам опроса врачей. Consortium Psychiatricum. 2021;2(2):35–44.

5. Незнанов Н.Г., Васильева А.В., Салагай О.О. Роль психотерапии, как медицинской специальности, в общественном здоровье. Общественное здоровье. 2022;2(2):40–57.

6. Петрова Н.Н., Савицкая К.С. Диагностика и терапия коморбидных тревожных и депрессивных расстройств в клинической практике. Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева. 2021;55(1):102-112.

7. Полуэктов М.Г. Возможности лечения инсомнии у пациентов с сопутствующими заболеваниями. Эффективная фармакотерапия. 2018;35:18-23.

8. Радионов Д.С., Караваева Т.А., Васильева А.В. Рыбакова К.В., Крупицкий Е.М., Прусова Т.И. Особенности злоупотребления алкоголем у лиц с тревожными расстройствами невротического спектра. Клинические аспекты и вопросы психотерапии. Вопросы наркологии. 2023;35(3):27-50.

9. Смулевич А.Б., Андрющенко А.В., Романов Д.В., Захарова Н.В. Ремиссии при аффективных заболеваниях: эпидемиология, психопатология, клинический и социальный прогноз, вторичная профилактика. Журнал неврологии и психиатрии им. С.С. Корсакова. 2014;114(3):4‑13.

10. Стаценко О.А., Усов Г.М. Симптомокомплекс агорафобии с паническим расстройством, коморбидный с депрессией. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2021;121(5‑2):49‑54.

11. Als TD, Kurki MI, Grove J et al. Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses. Nat Med. 2023;29(7):1832-1844. https://doi.org/10.1038/s41591-023-02352-1

12. Arnaud AM, Brister TS, Duckworth K, Foxworth P, Fulwider T, Suthoff ED, Werneburg B, Aleksanderek I, Reinhart ML. Impact of Major Depressive Disorder on Comorbidities: A Systematic Literature Review. J Clin Psychiatry. 2022;83(6):21r14328. https://doi.org/10.4088/JCP.21r14328

13. Asch SS. Claustrophobia and depression. J Am Psychoanal Assoc. 1966;14(4):711-29. https://doi.org/10.1177/000306516601400403

14. Baldwin D. Depression and panic: Comorbidity. Eur Psychiatry. 1998;13 Suppl 2:65s-70s. https://doi.org/10.1016/S0924-9338(98)80016-3

15. Bandelow B. Defining response and remission in anxiety disorders: toward an integrated approach. CNS Spectr. 2006;11(10 Suppl 12):21-8. https://doi.org/10.1017/s1092852900025815

16. Bandelow B, Allgulander C, Baldwin DS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders — Version 3. Part I: Anxiety disorders. World J Biol Psychiatry. 2023;24(2):79-117. https://doi.org/10.1080/15622975.2022.2086295

17. Bartholomay EM, Stone, BM, Lyons GA. Depression and social anxiety symptoms explain substance use problems beyond amount/frequency of substance use. Curr Psychol. 2023;42:6249–6256. https://doi.org/10.1007/s12144-021-01984-1

18. Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: developmen tal issues and implications for DSM-V. Psychiatr Clin North Am. 2009;32(3):483-524. https://doi.org/10.1016/j.psc.2009.06.002

19. Bekhuis E, Schoevers RA, van Borkulo CD, Rosmalen JG, Boschloo L. The network structure of major depressive disorder, generalized anxiety disorder and somatic symptomatology. Psychol Med. 2016;46(14):2989-2998. https://doi.org/10.1017/S0033291716001550

20. Bernstein GA. Comorbidity and severity of anxiety and depressive disorders in a clinic sample. Journal of the American Academy of Child and Adolescent Psychiatry. 1991;30(1):43–50. https://doi.org/10.1097/00004583-199101000-00007

21. Blatt SJ. Contributions of psychoanalysis to the understanding and treatment of depression. J Am Psychoanal Assoc. 1998;46(3):722-52

22. Boyd JH, Burke JD Jr, Gruenberg E, Holzer CE 3rd, Rae DS, George LK, Karno M, Stoltzman R, McEvoy L, Nestadt G. Exclusion criteria of DSM-III. A study of co-occurrence of hierarchy-free syndromes. Arch Gen Psychiatry. 1984;41(10):983-9. https://doi.org/10.1001/arch-psyc.1984.01790210065008

23. Brent DA, Kolko DJ, Birmaher B, Baugher M, Bridge J, Roth C, Holder D. Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. J Am Acad Child Adolesc Psychiatry. 1998;37(9):906-14. https://doi.org/10.1097/00004583-199809000-00010

24. Briley PM, Webster L, Boutry C, Cottam WJ, Auer DP, Liddle PF, Morriss R. Resting-state functional connectivity correlates of anxiety co-morbidity in major depressive disorder. Neurosci Biobehav Rev. 2022;138:104701. https://doi.org/10.1016/j.neubiorev.2022.104701

25. Busch FN, Milrod BL, Singer MB. Theory and technique in psychodynamic treatment of panic disorder. J Psychother Pract Res. 1999;8(3):234-42

26. Busch FN, Shear MK, Cooper AM, Shapiro T, Leon AC. An empirical study of defense mechanisms in panic disorder. J Nerv Ment Dis. 1995;183(5):299-303. https://doi.org/10.1097/00005053-199505000-00004

27. Calcia MA, Bonsall DR, Bloomfield PS, Selvaraj S, Barichello T, Howes OD. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology (Berl). 2016;233(9):1637-50. https://doi.org/10.1007/s00213-016-4218-9

28. Cameron OG. Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic functions. Essent Psychopharmacol. 2006;7(1):24-34.

29. Chavira DA, Stein MB, Bailey K, Stein MT. Child anxiety in primary care: prevalent but untreated. Depress Anxiety. 2004;20(4):155-64. https://doi.org/10.1002/da.20039

30. Choi KW, Kim YK, Jeon HJ. Comorbid Anxiety and Depression: Clinical and Conceptual Consideration and Transdiagnostic Treatment. Adv Exp Med Biol. 2020;1191:219-235. https://doi.org/10.1007/978-981-32-9705-0_14

31. Coombes BJ, Landi I, Choi KW et al. The genetic contribution to the comorbidity of depression and anxiety: a multi-site electronic health records study of almost 178 000 people. Psychol Med. 2023;53(15):7368-7374. https://doi.org/10.1017/S0033291723000983

32. Coryell W, Endicott J, Andreasen NC, Keller MB, Clayton PJ, Hirschfeld RM, Scheftner WA, Winokur G. Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry. 1988;145(3):293-300. https://doi.org/10.1176/ajp.145.3.293

33. Cougle JR, Hakes JK, Macatee RJ, Chavarria J, Zvolensky MJ. Quality of life and risk of psychiatric disorders among regular users of alcohol, nicotine, and cannabis: An analysis of the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). J Psychiatr Res. 2015;66-67:135-41. https://doi.org/10.1016/j.jpsychires.2015.05.004

34. Curtiss J, Klemanski DH. Taxonicity and network structure of generalized anxiety disorder and major depressive disorder: An admixture analysis and complex network analysis. J Affect Disord. 2016;199:99-105. https://doi.org/10.1016/j.jad.2016.04.007

35. Dalrymple KL, Zimmerman M. Does comorbid Social Anxiety Disorder impact the clinical presentation of principal Major Depressive Disorder? J Affect Disord. 2007;100(1-3):241-7. https://doi.org/10.1016/j.jad.2006.10.014

36. Finkelstein S, Weiss H. The Claustro-Agoraphobic Dilemma in Psychoanalysis: Fear of Madness (1st ed.). Routledge, 2022. https://doi.org/10.4324/9781003200284

37. Diaconu G, Turecki G. Panic disorder and suicidality: is comorbidity with depression the key? J Affect Disord. 2007;104(1-3):203-9. https://doi.org/10.1016/j.jad.2007.03.006.

38. Edmiston EK, Chase HW, Jones N, Nhan TJ, Phillips ML, Fournier JC. Differential role of fusiform gyrus coupling in depressive and anxiety symptoms during emotion perception. Soc Cogn Affect Neurosci. 2024;19(1):nsae009. https://doi.org/10.1093/scan/nsae009

39. Etchecopar-Etchart D, Korchia T, Loundou A, Llorca PM, Auquier P, Lançon C, Boyer L, Fond G. Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis. Schizophr Bull. 2021;47(2):298-308. https://doi.org/10.1093/schbul/sbaa153

40. Faravelli C, Castellini G, Benni L, Brugnera A, Landi M, Lo Sauro C, Pietrini F, Rotella F, Ricca V. Generalized anxiety disorder: is there any specific symptom? Compr Psychiatry. 2012;53(8):1056-62. https://doi.org/10.1016/j.comppsych.2012.04.002

41. Faust D, Miner RA. The empiricist and his new clothes: DSM-III in perspective. Am J Psychiatry. 1986;143(8):962-7. https://doi.org/10.1176/ajp.143.8.962

42. Feinstein AR. The Pre-Therapeutic Classification Of Co-Morbidity In Chronic Disease. J Chronic Dis. 1970;23(7):455-68. https://doi.org/10.1016/0021-9681(70)90054-8

43. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, Vos T, Whiteford HA. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547. https://doi.org/10.1371/journal.pmed.1001547

44. He C, Gong L, Yin Y, Yuan Y, Zhang H, Lv L, Zhang X, Soares JC, Zhang H, Xie C, Zhang Z. Amygdala connectivity mediates the association between anxiety and depression in patients with major depressive disorder. Brain Imaging Behav. 2019;13(4):1146-1159. https://doi.org/10.1007/s11682-018-9923-z

45. Hinwood M, Morandini J, Day TA, Walker FR. Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb Cortex. 2012;22(6):1442-54. https://doi.org/10.1093/cercor/bhr229

46. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171-86. https://doi.org/10.1097/PSY.0b013e3181907c1b

47. Hung CI, Liu CY, Yang CH, Gan ST. Comorbidity with more anxiety disorders associated with a poorer prognosis persisting at the 10-year follow-up among patients with major depressive disorder. J Affect Disord. 2020;260:97-104. https://doi.org/10.1016/j.jad.2019.08.085

48. Inkster B, Rao AW, Ridler K, Nichols TE, Saemann PG, Auer DP, Holsboer F, Tozzi F, Muglia P, Merlo-Pich E, Matthews PM. Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms. J Neuroimaging. 2011;21(4):375-82. https://doi.org/10.1111/j.1552-6569.2010.00515.x

49. Jegede O, Stefanovics EA, Rhee TG, Rosenheck RA. Multimorbidity and Correlates of Comorbid Depression and Generalized Anxiety Disorder in a Nationally Representative US Sample. J Nerv Ment Dis. 2023;211(5):355-361. https://doi.org/10.1097/NMD.0000000000001625

50. Johnson MR, Lydiard RB. Comorbidity of major depression and panic disorder. J Clin Psychol. 1998;54(2):201-10. https://doi.org/10.1002/(sici)1097-4679(199802)54:2<201::aid-jclp9>3.0.co;2-u

51. Kapadia M, Desai M, Parikh R. Fractures in the framework: limitations of classification systems in psychiatry. Dialogues Clin Neurosci. 2020;22(1):17-26. https://doi.org/10.31887/DCNS.2020.22.1/rparikh

52. Katz C, Yaseen ZS, Mojtabai R, Cohen LJ, Galynker II. Panic as an independent risk factor for suicide attempt in depressive illness: findings from the National Epidemiological Survey on Alcohol and Related Conditions (NESARC). J Clin Psychiatry. 2011;72(12):1628-35. https://doi.org/10.4088/JCP.10m06186blu

53. Keller MB. Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond. JAMA. 2003;289(23):3152-60. https://doi.org/10.1001/jama.289.23.3152

54. Kelly KM, Mezuk B. Predictors of remission from generalized anxiety disorder and major depressive disorder. J Affect Disord. 2017;208:467-474. https://doi.org/10.1016/j.jad.2016.10.042

55. Kennedy N, Foy K, Sherazi R, McDonough M, McKeon P. Long-term social functioning after depression treated by psychiatrists: a review. Bipolar Disord. 2007;9(1-2):25-37. https://doi.org/10.1111/j.1399-5618.2007.00326.x

56. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602. https://doi.org/10.1001/archpsyc.62.6.593

57. Lenze EJ, Mulsant BH, Mohlman J, Shear MK, Dew MA, Schulz R, Miller MD, Tracey B, Reynolds CF 3rd. Generalized anxiety disorder in late life: lifetime course and comorbidity with major depressive disorder. Am J Geriatr Psychiatry. 2005;13(1):77-80. https://doi.org/10.1176/appi.ajgp.13.1.77

58. Leonard BE, Myint A. The psychoneuroimmunology of depression. Hum Psychopharmacol. 2009;24(3):165-75. https://doi.org/10.1002/hup.1011

59. Lewinsohn PM, Gotlib IH, Seeley JR. Adolescent psychopathology: IV. Specificity of psychosocial risk factors for depression and substance abuse in older adolescents. J Am Acad Child Adolesc Psychiatry. 1995;34(9):1221-9. https://doi.org/10.1097/00004583-199509000-00021

60. Liu Y, Zhao J, Guo W. Emotional Roles of Mono-Aminergic Neurotransmitters in Major Depressive Disorder and Anxiety Disorders. Front Psychol. 2018;9:2201. https://doi.org/10.3389/fpsyg.2018.02201

61. Maj M. «Psychiatric comorbidity»: an artefact of current diagnostic systems? Br J Psychiatry. 2005;186:182-4. https://doi.org/10.1192/bjp.186.3.182

62. May R. Oedipal grief. Int J Psychoanal Psychother. 1978-1979;7:385-404.

63. McGrath JJ, Lim CCW, Plana-Ripoll O, et al. Comorbidity within mental disorders: a comprehensive analysis based on 145 990 survey respondents from 27 countries. Epidemiol Psychiatr Sci. 2020;29:e153. https://doi.org/10.1017/S2045796020000633.

64. Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Sokero TP, Isometsä ET. Current comorbidity of psychiatric disorders among DSMIV major depressive disorder patients in psychiatric care in the Vantaa Depression Study. J Clin Psychiatry. 2002;63(2):126-34.

65. Meller WH, Kathol RG, Samuelson SD, Gehris TL, Carroll BT, Pitts AF, Clayton PJ. CRH challenge test in anxious depression. Biol Psychiatry. 1995;37(6):376-82. https://doi.org/10.1016/0006-3223(94)00132-M

66. Mellick WH, Mills JA, Kroska EB, Calarge CA, Sharp C, Dindo LN. Experiential Avoidance Predicts Persistence of Major Depressive Disorder and Generalized Anxiety Disorder in Late Adolescence. J Clin Psychiatry. 2019;80(6):18m12265. https://doi.org/10.4088/JCP.18m12265

67. Milrod B. Separation Anxiety and Other Anxiety Disorders. In: Pini, S., Milrod, B. (eds) Separation Anxiety in Adulthood. Springer, Cham, 2023. https://doi.org/10.1007/978-3-031-37446-3_5

68. Moffitt TE, Harrington H, Caspi A, Kim-Cohen J, Goldberg D, Gregory AM, Poulton R. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry. 2007;64(6):651-60. https://doi.org/10.1001/archpsyc.64.6.651.

69. Morneau-Vaillancourt G, Coleman JRI, Purves KL, Cheesman R, Rayner C, Breen G, Eley TC. The genetic and environmental hierarchical structure of anxiety and depression in the UK Biobank. Depress Anxiety. 2020;37(6):512-520. https://doi.org/10.1002/da.22991

70. Nam YY, Kim CH, Roh D. Comorbid panic disorder as an independent risk factor for suicide attempts in depressed outpatients. Compr Psychiatry. 2016;67:13-8. https://doi.org/10.1016/j.comppsych.2016.02.011

71. Nordgaard J, Nielsen KM, Rasmussen AR, Henriksen MG. Psychiatric comorbidity: a concept in need of a theory. Psychol Med. 2023;53(13):5902-5908. https://doi.org/10.1017/S0033291723001605

72. Nutt DJ, Stein DJ. Understanding the neurobiology of comorbidity in anxiety disorders. CNS Spectr. 2006;11(10 Suppl 12):13-20. https://doi.org/10.1017/s1092852900025803

73. Ohayon MM, Schatzberg AF. Social phobia and depression: prevalence and comorbidity. J Psychosom Res. 2010;68(3):235-43. https://doi.org/10.1016/j.jpsychores.2009.07.018

74. Otte C. Incomplete remission in depression: role of psychiatric and somatic comorbidity. Dialogues Clin Neurosci. 2008;10(4):453-60. https://doi.org/10.31887/DCNS.2008.10.4/cotte

75. Paykel ES. Partial remission, residual symptoms, and relapse in depression. Dialogues Clin Neurosci. 2008;10(4):431-7. https://doi.org/10.31887/DCNS.2008.10.4/espaykel

76. Penninx BW, Nolen WA, Lamers F, et al. Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord. 2011;133(1-2):76-85. https://doi.org/10.1016/j.jad.2011.03.027

77. Plana-Ripoll O, Pedersen CB, Holtz Y, et al. Exploring Comorbidity Within Mental Disorders Among a Danish National Population. JAMA Psychiatry. 2019;76(3):259-270. https://doi.org/10.1001/jamapsychiatry.2018.3658

78. Pollack MH. Comorbid anxiety and depression. J Clin Psychiatry. 2005;66 Suppl 8:22-9.

79. Rakitzi S. Agoraphobia. In: Clinical Psychology and Cognitive Behavioral Psychotherapy. Springer, Cham, 2023. https://doi.org/10.1007/978-3-031-27837-2_8

80. Rao ML, Vartzopoulos D, Fels K. Thyroid function in anxious and depressed patients. Pharmacopsychiatry. 1989;22(2):66-70. https://doi.org/10.1055/s-2007-1014580

81. Rudden M, Busch FN, Milrod B, Singer M, Aronson A, Roiphe J, Shapiro T. Panic disorder and depression: a psychodynamic exploration of comorbidity. Int J Psychoanal. 2003;84(Pt 4):997-1015. https://doi.org/10.1516/002075703768284722

82. Rudenstine S, Espinosa A, Kumar A. Depression and Anxiety Subgroups Across Alcohol Use Disorder and Substance Use in a National Epidemiologic Study. J Dual Diagn. 2020;16(3):299-311. https://doi.org/10.1080/15504263.2020.1784498

83. Sareen J, Cox BJ, Afifi TO, et al. Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults. Arch Gen Psychiatry. 2005;62(11):1249-57. https://doi.org/10.1001/archpsyc.62.11.124

84. Shim IH, Woo YS, Bahk WM. Associations between immune activation and the current severity of the «with anxious distress» specifier in patients with depressive disorders. Gen Hosp Psychiatry. 2016;42:27-31. https://doi.org/10.1016/j.genhosppsych.2016.07.003

85. Sindermann L, Redlich R, Opel N, Böhnlein J, Dannlowski U, Leehr EJ. Systematic transdiagnostic review of magnetic-resonance imaging results: Depression, anxiety disorders and their co-occurrence. J Psychiatr Res. 2021;142:226-239. https://doi.org/10.1016/j.jpsychires.2021.07.022

86. Ter Meulen WG, Draisma S, van Hemert AM, et al. Depressive and anxiety disorders in concert-A synthesis of findings on comorbidity in the NESDA study. J Affect Disord. 2021;284:85-97. https://doi.org/10.1016/j.jad.2021.02.004

87. Troubat R, Barone P, Leman S, et al. Neuroinflammation and depression: A review. Eur J Neurosci. 2021;53(1):151-171. https://doi.org/10.1111/ejn.14720

88. Turna J, Simpson W, Patterson B, et al. Cannabis use behaviors and prevalence of anxiety and depres sive symptoms in a cohort of Canadian medicinal cannabis users. J Psychiatr Res. 2019;111:134-139. https://doi.org/10.1016/j.jpsychires.2019.01.024

89. van Balkom AJ, van BCA, Boeke AJ, et al. Comorbid depression, but comorbid anxiety disorders, predicts poor outcome in anxiety disorders. Depress Anxiety. 2008;25(5):408-15. https://doi.org/10.1002/da.20386

90. van Loo HM, Schoevers RA, Kendler KS, et al. Psychiatric comorbidity does not only depend on diagnostic thresholds: an illustration with major depressive disorder and generalized anxiety disorder. Depress Anxiety. 2016;33(2):143-52. https://doi.org/10.1002/da.22453

91. van Oudheusden LJ, Meynen G, van Balkom AJ. Psychiatrische comorbiditeit: theoretische en klinische dilemma’s. Tijdschr Psychiatr. 2015;57(9):664-71

92. van Tol MJ, Demenescu LR, van der Wee NJ, et al. Functional magnetic resonance imaging correlates of emotional word encoding and recognition in depression and anxiety disorders. Biol Psychiatry. 2012;71(7):593-602. https://doi.org/10.1016/j.biopsych.2011.11.016

93. van Tol MJ, van der Wee NJ, van den Heuvel OA, et al. Regional brain volume in depression and anxiety disorders. Arch Gen Psychiatry. 2010;67(10):1002-11. https://doi.org/10.1001/archgenpsychiatry.2010.121

94. Williams JB. The multiaxial system of DSM-III: where did it come from and where should it go? I. Its origins and critiques. Arch Gen Psychiatry. 1985;42(2):175-80. https://doi.org/10.1001/arch-psyc.1985.01790250069009

95. Zbozinek TD, Rose RD, Wolitzky-Taylor KB, et al. Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample. Depress Anxiety. 2012;29(12):1065-71. https://doi.org/10.1002/da.22026

96. Zellner MR, Watt DF, Solms M, Panksepp J. Affective neuroscientific and neuropsychoanalytic approaches to two intractable psychiatric problems: why depression feels so bad and what addicts really want. Neurosci Biobehav Rev. 2011;35(9):2000-8. https://doi.org/10.1016/j.neubiorev.2011.01.003

97. Zheng ZH, Tu JL, Li XH, et al. Neuroinflammation induces anxiety- and depressive-like behavior by modulating neuronal plasticity in the basolateral amygdala. Brain Behav Immun. 2021;91:505-518. https://doi.org/10.1016/j.bbi.2020.11.007